thenewsfacts.com
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
thenewsfacts.comthenewsfacts.com
Font ResizerAa
Search
  • Home
  • Latest News
  • Trending News
  • Entertainment
  • Technology
  • Sports
  • Business
  • Health
Follow US
© thenewsfacts : All Rights Reserved.

Home » COVAXIN now meets WHO safety profile – Soumya Swaminathan

COVID-19

COVAXIN now meets WHO safety profile – Soumya Swaminathan

TheNewsFacts
Last updated: July 9, 2021 11:34 am
TheNewsFacts
Share
COVAXIN now meets WHO safety profile - Soumya Swaminathan
SHARE

The desi vaccine developed by Bharat Biotech got a huge boost when the Chief Scientist at WHO said that the Indian COVID Vaccine COVAXIN meets the safety profile of the International Health Organisation.

This also silences the critics and instill great promise for Hyderabad-based vaccine Dr. Krishna Ella’s Bharat Biotech, to get nod for listing in World Health Organization (WHO) approved COVID vaccine. The company recently announced its Phase 3 trials conclusion demonstrating strong efficacy and protection against variants.

COVAXIN® Proven SAFE in India's Largest Efficacy Trial. Final Phase-3 Pre-Print Data Published on https://t.co/JJh9n3aB6V pic.twitter.com/AhnEg56vFN

— Bharat Biotech (@BharatBiotech) July 2, 2021

Soumya Swaminathan, the chief scientist at WHO told a Mumbai-based news organisation that the final phase trial data for Covaxin “looks good” and meets the safety profile of the international public health agency so far.

The pre-submission meeting between Bharat Biotech and WHO was held on June 23, Swaminathan told CNBC TV-18 in an interview, adding that the data packet is currently being assembled. She noted that although Covaxin’s efficacy against the Delta variant of Covid-19 is a bit low, it is still not bad, while the overall efficacy is “quite high.”

Bharat Biotech finally made public its findings from the Phase-3 efficacy analysis of Covaxin last Saturday, where it claimed an overall efficacy of 77.8% against symptomatic Covid-19 patients.

New data on Delta-Efficacy or Effectiveness (not🍎to🍎 comparison):

Pfizer: Wuhan=95% | Delta=64%
COVAXIN: Wuhan/Delta=78% | Delta=65%

All vaccines prevent >93% of hospitalizations. Regardless of the vaccine, get it, and wear a mask to get to near 100%.

— Dr. Raches Ella (@RachesElla) July 6, 2021

The pre-print data from “India’s largest efficacy trial” showed that Covaxin demonstrates 93.4% effectiveness against severe symptomatic Covid-19 cases. On the other hand, Covaxin provides 65.2% protection against the B.1.617.2 (Delta) strain, currently the most predominant Covid-19 variant in India, it said

Recently WHO chief said The world is at a perilous point in the #COVID19 pandemic. We have just passed the tragic milestone of 4 million recorded deaths, which likely underestimates the overall toll. It didn’t have to be this way and it doesn’t have to be this way going forward. #VaccinEquity

Share This Article
Twitter Email Copy Link Print
Previous Article Big Boss Sidharth Shukla slams reports of his split with Shenaaz Gill Big Boss Sidharth Shukla slams reports of his split with Shenaaz Gill
Next Article New Coach Rahul Dravid holds great promise for Indian Cricket - VVS Laxman New Coach Rahul Dravid holds great promise for Indian Cricket – VVS Laxman

Your Trusted Source for Accurate and Timely Updates!

We're committed to providing accurate and unbiased news as it unfolds, earning the trust of a large audience. Stay informed with our news updates on the latest events and trends, keeping you ahead of the curve.
FacebookLike
TwitterFollow
InstagramFollow

Popular Posts

T20 World Cup 2024: India vs Pakistan Clash, June 9 in New York Pop Up Arena

Here are the details of the India vs Pakistan T20 World Cup 2024: Match Date…

By TheNewsFacts

Cryptocurrency News Now: Firms Who Bet Big on Crypto are Struggling

Cryptocurrency News Now is not heartening, here is the round up on the cryptocurrency that…

By TheNewsFacts

Shyam Benegal: A Timeless Legacy That Changed Indian Cinema Forever

December 24, 2024: Shyam Benegal, the legendary director and screenwriter who revolutionized Indian cinema, passed…

By TheNewsFacts

You Might Also Like

Covaxin BHU Study
COVID VaccinesLatest News

Covaxin BHU Study: BB Points Flaws in Data Points, Backs Strong Safety Track Record

By NewsFacts Bureau
Covid-19 JN.!
COVID-19Health

JN.1, A New Subvariant of COVID-19 in Kerala: Health Ministry Vigilant

By SK Panicker
India's Covid-19 Cases Continue to Decline with 9,355 New Infections
COVID-19

India’s Covid-19 Cases Continue to Decline with 9,355 New Infections

By TheNewsFacts
COVAXIN
COVID Vaccines

COVAXIN production to be demand-driven, says Bharat Biotech

By TheNewsFacts
thenewsfacts thenewsfacts

About US


TheNewsFacts: Brings you the interesting facts, news facts and updates from India an the world across politics, tech, entertainment, business, tending, and more. We deliver what you love to read.
Top Categories
  • Latest News
  • Trending News
  • Paris Olympics 2024
  • Sports
  • Entertainment
  • Business
  • Technology
Usefull Links
  • About The News Facts
  • Latest News
  • Privacy Policy
  • Editorial Policy
  • Disclaimer
  • Contact Us
Follow us
Facebook Twitter Instagram

© thenewsfacts. All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?